| Date | Title | Description |
| 12.07.2025 | Datavant Completes Acquisition of Aetion | Datavant, a Phoenix, AZ-based health data platform company, completed the acquisition of Aetion, a real-world evidence (RWE) platform that powers critical decision-making in healthcare.
The amount of the deal was not disclosed.
Aetion is no... |
| 20.06.2025 | The Next Phase of RWE: Why Integration Matters More Than Data Collection | Natalie Schibell, VP of Market Strategy and Communications at Aetion,
Real-world evidence (RWE) has become central to evaluating therapies, medical products, and health interventions—providing insight into how they perform outside controlle... |
| 22.05.2025 | Datavant to Acquire Aetion | Datavant, a Phoenix, AZ-based company providing a health data platform, acquired Aetion, a NYC-based provider of a real-world evidence (RWE) platform that empowers critical decision-making in healthcare.
The amount of the deal was not discl... |
| 20.05.2025 | Datavant and Aetion: A New Era in Real-World Evidence | In the ever-evolving landscape of healthcare, data is the new gold. The recent announcement of Datavant's acquisition of Aetion marks a significant shift in how real-world evidence (RWE) will be harnessed to improve patient outcomes. This m... |
| 19.05.2025 | Health Data Company Datavant To Buy Aetion | Leading health data platform company Datavant announced that it has signed an agreement to acquire Aetion, a leading real-world evidence (RWE) platform that powers healthcare decision-making. With this deal, Aetion will join Datavant to del... |
| 16.05.2025 | Datavant to Acquire Real-World Evidence Platform Aetion | What You Should Know:
– Datavant, a health data platform company announced it has signed an agreement to acquire Aetion, a prominent real-world evidence (RWE) platform that powers critical decision-making in healthcare.
– The strategic comb... |
| 13.03.2025 | Define Ventures: Carolyn Magill Named As Venture Partner | Define Ventures, which is one of the largest venture capital firms focused on early-stage health tech companies, announced that Carolyn Magill, former CEO of Aetion, has joined the firm as venture partner. Magill, utilizing her 25 years of ... |
| 13.09.2024 | Aetion Announces Leadership Changes | Kevin Riley, industry leader with global experience in technology commercialization, joins as president
Carolyn Magill steps down as CEO; Jeremy Rassen, co-founder, continues as interim CEO
NEW YORK, Sept. 13, 2024 /PRNewswire/ -- Aetion®, ... |
| 24.06.2024 | Aetion Launches Barcelona Technology Hub and Appoints Ken Watson as Chief Technology Officer | BARCELONA, Spain, June 24, 2024 /PRNewswire/ -- Aetion®, the global leader in real-world evidence (RWE) technology and analytics, announced today the creation of an RWE technology hub in Barcelona, Spain, to convene the most capable group o... |
| 01.06.2023 | Все события в мире синтетических данных за 2022 год
Новые игроки и анализ рынка синтетических данных
Стратегические разработки
Развитие экосистемы... | В течение прошлого года мы наблюдали существенный рост в мире синтетических данных и радостные изменения на этом рынке. В своей статье я поделюсь своими заметками о годе мониторинга рынка. Из неё вы узнаете о новых игроках, разработках и пе... |
| 09.05.2023 | Aetion Launches New Application for Descriptive Analytics and Fast, Reliable Insights | Aetion, the global leader in real-world evidence technology and analytics, announced the launch of Aetion Discover, a new application for exploratory analysis. The application provides users with an intuitive interface to generate swift hyp... |
| 01.12.2022 | Contributed: How digital health can improve cancer care delivery | Photo: FG Trade/Getty Images |
| 22.01.2022 | What makes an engineer an all-star? Hint: It’s not being a star | Did you miss a session from the Future of Work Summit? Head over to our Future of Work Summit on-demand library to stream.
Ever heard of the “super chicken model?” Entrepreneur Margaret Heffernan eloquently and humorously unpacks the concep... |
| 22.01.2022 | What makes an engineer an all-star? Hint: It’s not being a star | We are excited to bring Transform 2022 back in-person July 19 and virtually July 20 - 28. Join AI and data leaders for insightful talks and exciting networking opportunities. Register today!
Ever heard of the “super chicken model?” Entrepre... |
| 01.12.2021 | European Medicines Agency Selects Aetion to Support Safety and Efficacy Research in Europe | BARCELONA, Spain, Dec. 1, 2021 /PRNewswire/ -- The European Medicines Agency (EMA) has selected Aetion for a four-year term to support the agency's Quality, Efficacy, and Safety Studies on Medicines. Aetion will perform pharmacoepidemiologi... |
| 01.12.2021 | European Medicines Agency Selects Aetion to Support Safety and Efficacy Research in Europe | The relationship covers a range of pharmacoepidemiologic studies on the utilisation, safety, and efficacy of medicines marketed across the European Union
BARCELONA, Spain, Dec. 1, 2021 /PRNewswire/ -- The European Medicines Agency (EMA) has... |
| 21.10.2021 | FDA Selects Aetion Evidence Platform to Assess In-Patient COVID-19 Treatments | What You Should Know:
– Aetion, a NYC-based leading real-world evidence (RWE) company, announced that the U.S. Food and Drug Administration (FDA) has contracted with them to use their Aetion Evidence Platform® to rapidly assess in-patient C... |
| 21.10.2021 | FDA Selects Aetion Evidence Platform® to Advance Regulatory Science and Innovation | NEW YORK, Oct. 21, 2021 /PRNewswire/ -- Today, Aetion announces that it is expanding its relationship with the U.S. Food and Drug Administration (FDA) to use real-world evidence (RWE) to study COVID-19 interventions and advance regulatory s... |
| 07.10.2021 | Aetion and NICE Announce Collaboration to Explore Use of Real-World Evidence for Comparative Effectiveness Studies to Inform Clinical Guidance | Aetion announced a collaboration with the National Institute for Health and Care Excellence (NICE) to explore how real-world evidence (RWE) can be used to study real-world clinical effectiveness. The collaboration aims to evaluate how RWE s... |
| 06.10.2021 | Aetion and NICE Announce Collaboration to Explore Use of Real-World Evidence for Comparative Effectiveness Studies to Inform Clinical Guidance | Collaboration will leverage the Aetion Evidence Platform® to study when and how RWE can support the agency's decision-making
NEW YORK, N.Y. and MANCHESTER, England, Oct. 6, 2021 /PRNewswire/ -- Aetion today announced a collaboration with th... |
| 06.10.2021 | Aetion and NICE Announce Collaboration to Explore Use of Real-World Evidence for Comparative Effectiveness Studies to Inform Clinical Guidance | NEW YORK, N.Y. and MANCHESTER, England, Oct. 6, 2021 /PRNewswire/ -- Aetion today announced a collaboration with the National Institute for Health and Care Excellence (NICE) to explore how real-world evidence (RWE) can be used to study real... |
| 14.09.2021 | Aetion Welcomes Marla Kessler as First Chief Customer Officer To Accelerate Its Next Phase of Growth | |
| 12.05.2021 | Aetion doubles lifetime funding with $110M series C for real-world data platform | Thanks to a 2020 spent proving the usefulness of its real-world evidence platform in rapidly responding to a global health crisis, Aetion has more than doubled its total venture funding to date with the close of a $110 million series C.
REL... |
| 12.05.2021 | Aetion doubles lifetime funding with $110M series C for real-world data platform | Thanks to a 2020 spent proving the usefulness of its real-world evidence platform in rapidly responding to a global health crisis, Aetion has more than doubled its total venture funding to date with the close of a $110 million series C.
Aet... |
| 11.05.2021 | Real-world evidence startup Aetion lands $110M in Series C as it looks toward global expansion | Photo: Getty Images/filadendron |
| 11.05.2021 | Aetion : Closes $110M Series C Funding Round Led by Warburg Pincus | BOSTON and NEW YORK, May 11, 2021 /PRNewswire/ -- Health care technology company Aetion announced today a $110 million Series C fundraise, led by Warburg Pincus, a leading global growth equity firm, with additional investments from B Capita... |
| 11.05.2021 | Aetion Closes $110M Series C Funding Round Led by Warburg Pincus | - |
| 11.05.2021 | Aetion Scoops Up $110M Series C Round |
NEW YORK, NY, Health care technology company Aetion announced today a $110 million Series C fundraise.
>> Click here for more funding data on Aetion
>> To export Aetion funding data to PDF and Excel, click here
The round ... |
| 11.05.2021 | Aetion closes $110M Series C funding round led by Warburg Pincus | Financing will advance Aetion’s technology, accelerate global growth, and drive expansion in new verticals, further cementing Aetion’s leadership position in real-world evidence |
| 11.05.2021 | Healthcare Tech Startup Aetion Raises $110M Series C Led by Warburg Pincus | Image: Shutterstock
Healthcare technology startup Aetion announced Tuesday it closed on a massive $110 million Series C round led by global growth equity firm Warburg Pincus, with participation from existing investors New Enterprise Associa... |
| 11.05.2021 | Aetion Raises $110M in Series C Funding | Aetion, a NYC-based healthcare technology company, raised $110m in Series C funding.
The round was led by Warburg Pincus, with participation from B Capital and Foresite Capital and existing backers New Enterprise Associates (NEA) and Flare ... |
| 10.03.2021 | Tausight Closes $20 Million Series A Financing to Discover and Help Secure Protected Health Information (PHI) | BOSTON — March 10, 2021 — Tausight today announced that it raised $20 million in Series A funding to help solve one of the most challenging responsibilities of healthcare CIOs and CISOs: ensuring the confidentiality, integrity, and availabi... |
| 19.11.2020 | A new study breathes life into an all-but-dead approach to treating severe Covid-19 | Maybe Roche’s IL-6 drug works for Covid-19 after all.
Actemra, the rheumatoid arthritis drug, was widely used by doctors early in the pandemic on the theory that it could douse the overactive immune response that leads to se... |
| 27.08.2020 | Aetion Secures $82M in Series B |
NEW YORK, NY, Aetion said Wednesday that it had raised the $19M extension to its Series B from JJDC, EDBI and Greenspring Associates, completing the $82M financing.
>> Click here for more funding data on Aetion
>> To export ... |
| 26.08.2020 | Aetion completes $82M Series B round with $19M extension | “Aetion has had an impactful year, bringing RWE to the forefront of drug research and development with key stakeholders across the industry,” former Food and Drug Administration commissioner and Aetion board director Scott Gottlieb said in ... |
| 26.08.2020 | Aetion Raises Further $19M; Closes $82M Series B Round | Aetion, a NYC-based health care technology company that delivers real-world evidence (RWE) for biopharma companies, payers, and regulatory agencies, raised a $19m extension to its Series B funding round.
Backers included new shareholders Jo... |
| 26.08.2020 | Aetion pushes Series B to $82M as pandemic puts real-world evidence under the spotlight | Former FDA chief Scott Gottlieb’s favorite real-world evidence platform is getting a new stream of cash, as it nears what will likely be the biggest test of the young company so far.
Aetion, the New York health tech startup, ha... |
| 26.08.2020 | Healthcare data company Aetion raises $19 million | The company provies real-world data to help organizations make better clinical decisions
One of the major problems in all healthcare systems is knowing which treatments work best for which patient, and who should pay for them. That lack of ... |
| 26.08.2020 | Real-world evidence platform Aetion adds $19M to last year's Series B raise | |
| 26.08.2020 | Aetion adds strategic investment from Johnson & Johnson Innovation - JJDC, Inc., EDBI, Greenspring Associates to expand RWE offerings | |
| 20.05.2020 | FDA, Aetion team up on real-world evidence research in Covid-19 | The effort will involve identifying and analyzing sources of data to characterize populations of patients with Covid-19, their use of medications, risk factors for complications related to the disease and to characterize potential intervent... |
| 19.07.2019 | Some of the top precision health startups funded in 2019 | The precision medicine space is expected to grow to over $216.75 billion by 2028
Precision health, which is medicine that is tailored to each individual person, using their genes to figure out what treatments will work best for that individ... |
| 01.04.2019 | Purveyor of real world evidence wants to eliminate health care’s blindspots | The use of real world data to assess the safety and effectiveness of drugs and medical treatments is among the most controversial topics in medicine. As chief executive of Aetion, a New York City startup that sells software to analyze those... |
| 06.02.2019 | Daily funding roundup - February 6th, 2019 | MakerSights raised $3.1M; productboard raised $10M; Jetty secured $25M; CathWorks raised $30M
MakerSights: MakerSights is a leading provider of product development software for consumer brands. MakerSights has raised $3.1 million in funding... |
| 06.02.2019 | Term Sheet — Wednesday, February 6 | A PODCASTING EMPIRE
Good morning, Term Sheet readers.
Paid Content You can't secure what you can't see From ExtraHop
Gimlet had raised approximately $28.5 million in venture funding from investors including WPP, Stripes Group, LionTree Part... |
| 06.02.2019 | Aetion Raises $27M in Funding | Aetion, a NYC-based health care technology company, raised $27 in further Series B funding.
Coupled with its prior funding in early 2018, the investment caps the total Series B funding at $63m. This brings Aetion’s total funding to $77 mill... |
| 05.02.2019 | Aetion's real-world data analytics platform raises $27M, caps off $63M Series B round | |
| 05.02.2019 | Aetion secures $27 million strategic investment to accelerate growth and expand its RWE platform | Aetion (pronounced eh-tee-ahn), a healthtech startup that delivers real-world evidence (RWE) and outcomes-based analytics solutions to life science companies and payers, has raised $27 million strategic capital infusion to strengthen its Ev... |
| 05.02.2019 | Aetion Announces $27M Funding |
NEW YORK, NY, Aetion, a healthcare technology company, has raised $27 million in funding.
>> Click here for more funding data on Aetion
>> To export Aetion funding data to PDF and Excel, click here
Aetion, the health care... |
| 04.02.2019 | Health care startup Aetion raises $27 million for real-world evidence platform | Aetion, a four-year-old health care startup that aims to bridge the gap between providers, payers, and biopharmaceutical companies with a novel analytics solution, today announced that it has raised $27 million in an expanded series B round... |
| 04.02.2019 | Health care startup Aetion raises $27 million for real-world evidence platform | Did you miss a session from GamesBeat Summit 2022? All sessions are available to stream now. Learn more.
Aetion, a four-year-old health care startup that aims to bridge the gap between providers, payers, and biopharmaceutical companies with... |
| 20.09.2018 | Andy Slavitt’s Town Hall Ventures secures $115M for first fund | Founded earlier this year, Town Hall Ventures is led by Andy Slavitt, who was the acting administrator of CMS under the Obama administration; Trevor Price, founder and CEO of Oxeon Holdings; and David Whelan, who previously served as genera... |
| 07.08.2018 | Which New York City healthcare companies raised the most dough from investors in Q2? | Thrive Global, the consumer wellness platform headed up by Arianna Huffington, was at the top of the list. In May, it announced it brought in $43 million.
Aetion, which focuses on real-world data through the science and analytics platform i... |
| 08.05.2018 | Andy Slavitt joins new venture firm investing in tech to support Medicaid, Medicare members | Slavitt will lead Town Hall Ventures with Trevor Price, founder of executive search and investment firm Oxeon Ventures and CEO of Oxeon Partners, and David Whelan, who previously served as general partner and CFO of the private equity firm ... |
| 14.04.2018 | Aetion Announces $36 Million in Series B | Aetion, the software platform company delivering the real-world analytics and evidence needed for biopharma and payers to engage in value-based care, announced it has raised $36.4 million in Series B funding. The round was led by New Enterp... |
| 12.04.2018 | Real-world evidence platform developer Aetion nabs Amgen-backed $36M series B | The passage of the 21st Century Cures Act spurred growing interest in the use of real-world data for drug development and regulatory processes. Venture capitalists have noticed that trend and are putting big money behind a company that deve... |
| 11.04.2018 | Aetion Announces $36 Million in Series B Funding | Aetion, the software platform company delivering the real-world analytics and evidence needed for biopharma and payers to engage in value-based care, announced it has raised $36.4 million in Series B funding. The round was led by New Enterp... |
| 11.04.2018 | Healthtech platform Aetion raises $36.4M to hire engineers and others | image via shutterstock
To those not in the healthcare industry, the term “value-based care” can seem like a given. People might assume that prescribing medications with a proven track record is just the way healthcare professionals operate.... |
| 11.04.2018 | Aetion Announces $36 Million in Series B Funding to Accelerate Its Platform for the Analysis of Real-World Evidence to Biopharma Companies and Health Care Payers | Aetion, the software platform company delivering the real-world analytics and evidence needed for biopharma and payers to engage in value-based care, announced it has raised $36.4 million in Series B funding. The round was led by New Enterp... |
| 11.04.2018 | Aetion Raises $36M in Series B Funding | Aetion, a NYC-based software platform company delivering real-world analytics and evidence to biopharma and payers, raised $36.4m in Series B funding.
The round was led by New Enterprise Associates (NEA) with participation fro new investor ... |
| 11.04.2018 | Aetion Raises $36M to Expand Evidence Analytics Platform for Value-Based Care | Aetion, a software platform company that delivers real-world analytics and evidence needed for biopharma and payers to engage in value-based care, has raised $36.4 million in Series B funding. The round was led by New Enterprise Associates ... |
| 11.04.2018 | Aetion Announces $36M in Series B |
NEW YORK, NY, Aetion has raised $36.4 million in Series B funding led by New Enterprise Associates.
>> Click here for more funding data on Aetion
>> To export Aetion funding data to PDF and Excel, click here
Aetion, the s... |
| 26.09.2017 | Aetion Appoints Carolyn Magill as CEO | Healthcare technology veteran Carolyn Magill has been appointed CEO of Aetion, a leader in delivering real-world evidence (RWE) and outcomes-based analytics solutions to life science companies and payers. Ms. Magill brings two decades of ex... |
| 20.03.2017 | Flare Capital Leads $11.2M Series A for Aetion | Aetion, a leading healthcare technology company that provides real-world evidence (RWE) analytics solutions for payer/provider, biopharma and medical device customers, today announced that it has secured $11.2 million in Series A funding in... |
| 20.03.2017 | Aetion Raises $11.2 Million Series A | Aetion, a leading healthcare technology company that provides real-world evidence (RWE) analytics solutions for payer/provider, biopharma and medical device customers, today announced that it has secured $11.2 million in Series A funding in... |
| 20.03.2017 | Term Sheet — Monday, March 20 | BACK + THANKS
Good morning! It’s me, your regular host, back from vacation. I actually succeeded in unplugging so this morning’a agenda is catching up on three weeks worth of news (Snap IPO! Greyball! Trump tax plan!) and wading through app... |
| 20.03.2017 | Aetion Raises $11.2 Million in Series A Funding | - |
| 20.03.2017 | Aetion Secures $11.2M in Series A Funding | Aetion, a NYC-based healthcare technology company, secured $11.2m in Series A funding.
The round was led by Flare Capital Partners and joined by Lakestar.
The company intends to use the funds to extend the capabilities of its platform, as w... |
| 20.03.2017 | Aetion Raises $11.2M in Series A |
NEW YORK, NY, Leading healthcare technology company has secured $11.2 million in Series A funding led by Flare Capital Partners.
>> Click here for more funding data on Aetion
>> To export Aetion funding data to PDF and Excel... |
| 20.03.2017 | Aetion Raises $11.2M for Real-World Evidence Data Analytics Platform | Aetion, a NYC-based healthcare technology company that delivers the real-world analytics and evidence needed for value-based healthcare has raised $11.2 million in Series A funding led by Flare Capital Partners and joined by Lakestar. The c... |
| 20.03.2017 | Aetion gets $11.2M for real-world evidence analytics platform | New York-based healthcare technology company, Aetion, which makes an analytics platform to assess real-world evidence from a range of sources, has raised $11.2 million in Series A funding. Flare Capital Partners, a VC firm focused on early ... |
| - | Investor insights: Blake Wu of NEA | Investors and healthcare startups are center stage at the annual INVEST conference in Chicago March 28-30, 2022. In the runup to the conference, we’re doing a series of interviews with investors on their approach to startups across the four... |
| - | Which New York City healthcare companies raised the most dough from investors in Q2? | A new report from New York City Health Business Leaders found that during the second quarter of 2018, investors poured more than $300 million into healthcare startups based in the Big Apple.
The investment update also provides a closer look... |
| - | Aetion Adds Another $19M to its Series B to Make Sense of Drug Development and Treatment Data | 532SHARES
FacebookTwitter
Linkedin
In April, Aetion, the Real World Evidence Platform®, partnered with HealthVerity to launch a real-time treatment tracker for COVID-19, allowing doctors and researchers to assess outcomes and how treatments... |
| - | Aetion Raises Another $27M To Empower the Health Care Industry With Real Big Data | 442SHARES
FacebookTwitter
Linkedin
Most people have read about an exciting, “breakthrough” in medicine and only to discover a couple paragraphs later that the results are based upon a sample size of 30 people, but Aetion uses real-world dat... |
| - | Andy Slavitt joins new venture firm investing in tech to support Medicaid, Medicare members | At the JP Morgan Healthcare conference earlier this year, former CMS administrator Andy Slavitt cast a spotlight on the need for healthcare innovations that would help the most vulnerable patient populations, not just the worried well. The ... |
| - | FDA, Aetion team up on real-world evidence research in Covid-19 | A firm that generates real-world evidence for the life sciences industry is teaming up with the Food and Drug Administration in a push to use real-world data to understand and respond to Covid-19.
New York-based Aetion said Tuesday that the... |
| - | Aetion Closes $100M to Expand RWE Analytics Platform | What You Should Know:
– Healthcare technology company Aetion announced today a $110M Series C fundraise, led by Warburg Pincus, a leading global growth equity firm, with additional investments from B Capital and Foresite Capital. Aetion’s e... |
| - | Aetion completes $82M Series B round with $19M extension | A data analytics firm focused on generating real-world evidence has raised an extension that completes its Series B funding round.
New York-based Aetion said Wednesday that it had raised the $19 million extension to its Series B, completing... |
| - | Andy Slavitt’s Town Hall Ventures secures $115M for first fund | Town Hall Ventures, an investment firm that backs companies supporting vulnerable populations covered by Medicare and Medicaid, has closed its first fund at a total of $115 million.
The firm raised the fund from four of the five largest non... |
